Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
1.280
-0.080 (-5.88%)
At close: Oct 31, 2024, 4:00 PM
1.300
+0.020 (1.56%)
After-hours: Oct 31, 2024, 5:12 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $105.47 million as of October 31, 2024. Its market cap has increased by 63.27% in one year.
Market Cap
105.47M
Enterprise Value
-92.87M
1-Year Change
63.27%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since January 26, 2018, Adicet Bio's market cap has decreased from $459.10M to $105.47M, a decrease of -77.03%. That is a compound annual growth rate of -19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 112.10M | 37.38% |
| Dec 29, 2023 | 81.60M | -78.70% |
| Dec 30, 2022 | 383.10M | -31.45% |
| Dec 31, 2021 | 558.90M | 102.94% |
| Dec 31, 2020 | 275.40M | 407.18% |
| Dec 31, 2019 | 54.30M | -77.54% |
| Dec 31, 2018 | 241.80M | -47.33% |
| Jan 26, 2018 | 459.10M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 119.14M |
| Rockwell Medical | 118.85M |
| Century Therapeutics | 118.60M |
| KORU Medical Systems | 118.31M |
| OptiNose | 118.13M |
| 908 Devices | 117.49M |
| TriSalus Life Sciences | 116.95M |
| Aclaris Therapeutics | 114.86M |